Cathie Wood Seres Therapeutics, Inc. Transaction History

Ark Investment Management LLC

$10.5 Billion
Q3 2024

20 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2021 Nov 12, 2021	SELL	$5.46 - $22.6 $53 Million - $220 Million	-9,713,160 Closed	0 $0
Q2 2021 Aug 05, 2021	SELL	$18.46 - $24.36 $39.6 Million - $52.2 Million	-2,142,787 Reduced 18.07%	9,713,160 $232 Million
Q1 2021 May 13, 2021	SELL	$17.66 - $28.92 $33.3 Million - $54.5 Million	-1,885,307 Reduced 13.72%	11,855,947 $244 Million
Q4 2020 Feb 12, 2021	BUY	$23.25 - $37.73 $33.7 Million - $54.6 Million	1,448,221 Added 11.78%	13,741,254 $337 Million
Q3 2020 Oct 30, 2020	SELL	$3.74 - $28.74 $695,269 - $5.34 Million	-185,901 Reduced 1.49%	12,293,033 $348 Million
Q2 2020 Aug 11, 2020	BUY	$3.04 - $6.2 $11.6 Million - $23.8 Million	3,831,623 Added 44.31%	12,478,934 $59.4 Million
Q1 2020 May 14, 2020	BUY	$2.64 - $3.82 $3.63 Million - $5.25 Million	1,373,471 Added 18.88%	8,647,311 $30.9 Million
Q4 2019 Jan 31, 2020	BUY	$2.99 - $4.42 $594,636 - $879,027	198,875 Added 2.81%	7,273,840 $25.1 Million
Q3 2019 Nov 12, 2019	BUY	$2.29 - $4.16 $82,623 - $150,092	36,080 Added 0.51%	7,074,965 $28.4 Million
Q2 2019 Jul 30, 2019	BUY	$2.28 - $7.35 $3.99 Million - $12.9 Million	1,751,172 Added 33.12%	7,038,885 $22.7 Million
Q1 2019 May 13, 2019	BUY	$4.83 - $7.21 $5.64 Million - $8.42 Million	1,168,234 Added 28.36%	5,287,713 $36.3 Million
Q4 2018 Feb 01, 2019	BUY	$4.52 - $8.88 $355,922 - $699,246	78,744 Added 1.95%	4,119,479 $18.6 Million
Q3 2018 Nov 07, 2018	BUY	$7.33 - $9.23 $5.68 Million - $7.15 Million	774,307 Added 23.71%	4,040,735 $30.7 Million
Q2 2018 Aug 07, 2018	BUY	$6.91 - $9.55 $5.94 Million - $8.21 Million	859,705 Added 35.72%	3,266,428 $28.1 Million
Q1 2018 May 14, 2018	BUY	$7.34 - $11.16 $5.73 Million - $8.72 Million	781,222 Added 48.06%	2,406,723 $17.7 Million
Q4 2017 Feb 12, 2018	BUY	$9.15 - $12.64 $6.7 Million - $9.26 Million	732,579 Added 82.04%	1,625,501 $16.5 Million
Q3 2017 Nov 09, 2017	BUY	$12.81 - $16.85 $1.64 Million - $2.15 Million	127,731 Added 16.69%	892,922 $14.3 Million
Q2 2017 Aug 11, 2017	BUY	N/A	135,276 Added 21.48%	765,191 $8.65 Million
Q1 2017 May 15, 2017	BUY	N/A	137,851 Added 28.01%	629,915 $7.1 Million
Q4 2016 Feb 13, 2017	BUY	N/A	492,064	492,064 $4.87 Million

Others Institutions Holding MCRB

# of Institutions

Shares Held

40.5M

Call Options Held

304K

Put Options Held

471K

Flagship Pioneering Inc. Cambridge, MA

23.1M
Shares

$20.3 Million
3.73% of portfolio
Vanguard Group Inc Valley Forge, PA

6.06M
Shares

$5.33 Million
0.0% of portfolio
Black Rock Inc. New York, NY

1.76M
Shares

$1.55 Million
0.0% of portfolio
Geode Capital Management, LLC Boston, MA

1.39M
Shares

$1.22 Million
0.0% of portfolio
Susquehanna International Group, LLP Bala Cynwyd, PA

1.19M
Shares

$1.05 Million
0.0% of portfolio

View Full List

About Seres Therapeutics, Inc.

Ticker MCRB
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 124,072,000
Market Cap $109M
Description
Seres Therapeutics, Inc., a microbiome therapeutics platform company, engages in developing bacterial consortia that are designed to functionally interact with host cells and tissues to treat disease. The company's lead product candidate is the SER-109, an oral microbiome therapeutic candidate that has completed Phase III clinical trial for the ...

More about MCRB

Track Cathie Wood's Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Ark Investment Management LLC, based on Form 13F filings with the SEC.

News

Stay updated on Ark Investment Management LLC and Cathie Wood with notifications on news.

Account